-
-
Pharma & Human Health -
Finance -
Editor's Choice -
Pharma & Human Health
Editor’s Choice
Editor's Choice
EXPERT’Biome CDMO by Lallemand at Microbiome Times Forum
With Expert’Biome™, Lallemand Health Solutions aims to support partners in their development of next-generation strains by offering comprehensive services in the health industry. These services include strains research and development, bioprocesses scaling, drug manufacturing, and […]
Editor's Choice
DynaMAP – Precision Metagenomics beyond Sequencing
At the Microbiome Times Partnering Forum, Arno Bouwens, R&D Director at Perseus Biomics, took to the stage to present their technology, DynaMAP (Dynamic Microbiome Abundance Profiling), for high-resolution microbiome analysis. His talk, titled “DynaMAP – […]
Editor's Choice
The Selection of a Pre-Clinical Model is Driven by the Specific Research Question
At the Microbiome Times Partnering Forum, Massimo Marzorati, CEO of ProDigest, presents “The Selection of a Pre-Clinical Model is Driven by the Specific Research Question”. A talk highlighting the company’s expertise in simulating the gastrointestinal […]
In Case you Missed it:
Pharma & Human Health
InnoGI Technologies Unveils its Advanced Gut Microbiome Model (TIM-2) By Incorporating Mucus
Introduction InnoGI Technologies a leading Contract Research Organization (CRO) specializing in gastrointestinal (GI) modeling, today announced promising results from a validation study of its enhanced in vitro colon model, TIM-2muc. By incorporating a physiologically relevant […]
Finance
32 Biosciences receives $6 million in funding to advance gut microbiome platform technologies
32 Biosciences announced it has received $6 million in funding to support the continued development of its lead assets. The funding comes as the company prepares for a future Series A fundraise and advances toward key […]
Finance
MaaT Pharma Submits Marketing Authorization Application to the European Medicines Agency (EMA) for Xervyteg®
MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for patients with cancer through immune modulation, announced the […]
Editor's Choice
DynaMAP – Precision Metagenomics beyond Sequencing
At the Microbiome Times Partnering Forum, Arno Bouwens, R&D Director at Perseus Biomics, took to the stage to present their technology, DynaMAP (Dynamic Microbiome Abundance Profiling), for high-resolution microbiome analysis. His talk, titled “DynaMAP – […]
Editor's Choice
The Selection of a Pre-Clinical Model is Driven by the Specific Research Question
At the Microbiome Times Partnering Forum, Massimo Marzorati, CEO of ProDigest, presents “The Selection of a Pre-Clinical Model is Driven by the Specific Research Question”. A talk highlighting the company’s expertise in simulating the gastrointestinal […]
Pharma & Human Health
A symbiotic gut fungus wards off liver disease in mice
Researchers have found a new ally in the fight against a serious liver disease: a symbiotic gut-dwelling fungus that produces a molecule shown to be capable of reversing disease progression in mice. The findings may […]
Pharma & Human Health
Study of facial bacteria could lead to probiotics that promote healthy skin
The composition of bacterial populations living on our faces plays a significant role in the development of acne and other skin conditions such as eczema. Two species of bacteria predominate in most people, but how […]
Pharma & Human Health
No more copy-pasting: DNA base editing for better Lactobacillus strains
A Kobe University team was able to edit the DNA of Lactobacillus strains directly without a template from other organisms. This technique is indistinguishable from natural variation and enabled the researchers to create a strain that doesn’t […]
